Biomea Fusion Correlations
BMEA Stock | USD 6.44 0.06 0.94% |
The current 90-days correlation between Biomea Fusion and Design Therapeutics is 0.04 (i.e., Significant diversification). The correlation of Biomea Fusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Biomea Fusion Correlation With Market
Average diversification
The correlation between Biomea Fusion and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biomea Fusion and DJI in the same portfolio, assuming nothing else is changed.
Biomea |
Moving together with Biomea Stock
Moving against Biomea Stock
0.61 | MDGL | Madrigal Pharmaceuticals | PairCorr |
0.57 | KEP | Korea Electric Power | PairCorr |
0.55 | RNXT | RenovoRx | PairCorr |
0.34 | CYRX | Cryoport | PairCorr |
0.53 | VFSWW | VinFast Auto | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Biomea Stock performing well and Biomea Fusion Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biomea Fusion's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
EWTX | 3.54 | 0.64 | 0.24 | 0.35 | 2.85 | 6.65 | 61.02 | |||
HOWL | 0.00 | (0.33) | 0.00 | 0.40 | 0.00 | 8.33 | 49.02 | |||
CGEM | 2.87 | (0.44) | 0.00 | 0.82 | 0.00 | 5.88 | 17.85 | |||
DSGN | 3.97 | 0.22 | 0.02 | 11.77 | 5.40 | 8.54 | 35.31 | |||
IKNA | 1.09 | (0.07) | (0.07) | (0.01) | 1.39 | 1.81 | 13.50 |
Biomea Fusion Corporate Management
Juan MD | Chief Officer | Profile | |
Caroline Dupont | Senior Contracts | Profile | |
Naomi Cretcher | Chief Officer | Profile | |
Heow Tan | Chief Officer | Profile | |
Stephan MD | Chief Officer | Profile | |
Franco Valle | CFO Officer | Profile |